Telaprevir-induced acquired perforating dermatosis

Article de revue

Avec comité de lecture

Charlotte Pernet, Georges-Philippe Pageaux, Bernard Guillot, Olivier Dereure et Didier Bessis

JAMA dermatology (Chicago, Ill.), Vol.150(12), pp.1371-1372

12/2014

PMID: 25251868

Résumé

Antiviral Agents - adverse effects

Drug Eruptions - etiology

Hepatitis C, Chronic - drug therapy

Humans

Leg Ulcer - chemically induced

Leg Ulcer - pathology

Male

Middle Aged

Oligopeptides - adverse effects

1 Consultations de la notice

Titre: Telaprevir-induced acquired perforating dermatosis
Créateurs - sans rôle: Charlotte Pernet - Department of Dermatology, St Eloi Hospital, Montpellier, France2University of Montpellier I, Montpellier, France3Department of Pathology, Gui de Chauliac Hospital, Montpellier, France
Georges-Philippe Pageaux - Department of Dermatology, St Eloi Hospital, Montpellier, France2University of Montpellier I, Montpellier, France4Liver Transplant Unit, St Eloi Hospital, Montpellier, France
Bernard Guillot - Department of Dermatology, St Eloi Hospital, Montpellier, France2University of Montpellier I, Montpellier, France5INSERM (Institut national de la santé et de la recherche médicale) U1058, Montpellier, France
Olivier Dereure - Department of Dermatology, St Eloi Hospital, Montpellier, France2University of Montpellier I, Montpellier, France5INSERM (Institut national de la santé et de la recherche médicale) U1058, Montpellier, France
Didier Bessis - Department of Dermatology, St Eloi Hospital, Montpellier, France2University of Montpellier I, Montpellier, France5INSERM (Institut national de la santé et de la recherche médicale) U1058, Montpellier, France
Détails de publication: JAMA dermatology (Chicago, Ill.), Vol.150(12), pp.1371-1372
Identifiants: 99156956809311
Unité académique: Pathogenesis and Control of Chronic and Emerging Infections - PCCEI
Langue: English
Type de ressource: Journal article